早期生活中暴露于巴比塔尔会对海马体的转录基因组产生失调
Seán Quinlan1, Tahiyana Khan1,2, David McFall1,2
1Department of Physiology and Pharmacology, Georgetown University, Washington, DC, United States.
Frontiers in pharmacology
|April 12, 2024
概括
巴比他 (PB) 在新生儿大脑中引起广泛的基因表达变化,与 levetiracetam (LEV) 不同. 发育中的大脑中的这种转录基因变化可能解释了PBPB.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 巴比他 (PB) 和 levetiracetam (LEV) 是新生儿的第一线治疗方法.
- 人们担心PB可能会产生持久的神经发育毒性.
- 这些药物对新生儿大脑的转录基因格局的影响尚未完全理解.
研究的目的:
- 为了研究PB和LEV对新生小鼠海马体转录组的影响.
- 为了比较PB和LEV暴露在关键神经发育窗口期间引起的转录组变化.
主要方法:
- 新生小鼠幼接收了一剂PB,LEV或载体.
- 河马RNA测序是在服用药物后72小时进行的.
- 进行了差异基因表达分析,以确定转录基因变异.
主要成果:
- PB暴露导致124个差异表达的转录,而LEV暴露只影响了15个转录.
- PB显著降低了GABAergic和寡类细胞标记物 (pvalb,opalin).
- PB暴露增加了微质激活 (cd68) 和天体细胞活性 (vegfa) 的标志物.
结论:
- 在发育中的大脑中,PB诱导了广泛的转录基因变化,这表明与神经毒性有关.
- 与PB相比,LEV似乎对新生儿转录组的影响很小.
- 这些发现突显了PB在关键神经发育时期破坏多种细胞类型和分子通路的潜力.
相关概念视频
Sedatives and Hypnotics Drugs: Barbiturates
1.5K
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.5K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
948
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
948
Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410


